Inactive Instrument
Liminal BioSciences Inc. Stock
Stocks
PJ2
CA53272L2021
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Pritchard
CEO | Chief Executive Officer | 53 | 2020-11-12 |
| Director of Finance/CFO | 53 | 2022-03-01 | |
Marie Iskra
LAW | General Counsel | 50 | 2019-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alek Krstajic
CHM | Chairman | 62 | 2020-08-31 |
Eugene Siklos
BRD | Director/Board Member | 62 | 2020-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/23 | Thomvest Asset Management, Inc.
| Tax | Company | 17,888,516 | - | |
| 10/1/23 | Thomvest Asset Management, Inc.
| Marche | Company | 1,261,921 | 38.8339% | |
| 10/1/23 | Thomvest Asset Management, Inc.
| Tax | Company | 17,888,516 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +6.09% | - | - | 13.02M | |
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.16B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.16B | |
| -2.91% | -4.54% | +23.19% | +50.52% | 45.33B | |
| -0.32% | -2.13% | +19.90% | +98.04% | 42.25B | |
| +0.53% | +2.22% | +224.67% | +941.61% | 40.78B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | +0.02% | +4.72% | +53.28% | +164.24% | 43.63B | |
| Weighted average by Cap. | -0.05% | +3.64% | +50.07% | +162.59% |
Employees
-
